Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
Swedencare AB (publ)
sales of 85.49 million Swedish Kronor [US$9.38 million]
(9.51 million Euro [US$10.88 million]
of which 55%
was Operating segment - Europe), and
based in Russia
(723.50 million Russian Rubles [US$10.75 million]
Biohit Oyj reported sales of 8.98 million Euro (US$10.27 million)
December of 2017.
increase of 9.6%
versus 2016, when the company's sales were 8.20 million Euro.
Sales at Biohit Oyj have increased during each of the previous five years
(and since 2012, sales have increased a total of 338%).